19 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
March 2022, the former Vice President, Strategic Drug Development, Quintiles Transnational and former Vice President, R&D and Scientific Leader … to the
Lead any relevant or material updates to non-confidential and confidential slide decks with support from key Company individuals including R&D
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
through March 2022, the former Vice President, Strategic Drug Development, Quintiles Transnational and former Vice President, R&D and Scientific Leader … to the
Lead any relevant or material updates to non-confidential and confidential slide decks with support from key Company individuals including R&D
6-K
EX-99.1
XRTX
XORTX Therapeutics Inc
27 Jun 23
XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company’s Upcoming Annual and Special Meeting of Shareholders
2:15pm
experienced and skilled R&D team and our broadly experienced board of directors. As the Company advances our late stage program in ADPKD toward the start
6-K
EX-99.3
qlncwnnjv9
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
sx4mky
28 Nov 22
XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
7:00am
6-K
EX-99.1
d3lsx p8701bgqjc8pkc
19 Sep 22
XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
7:00am
6-K
EX-99.1
i2japweu
4 Aug 22
XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
7:00am
6-K
EX-99.1
8nvm4
19 Jul 22
XORTX Announces Submission to European Medicines Agency
7:00am
6-K
EX-99.1
teh8 u7i8fz
7 Jul 22
Current report (foreign)
7:00am
6-K
EX-99.1
6m37qeejv1uzrzgy e7
29 Jun 22
Current report (foreign)
9:58pm
20-F
pf79583
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
u2u5cs4ho8ids2l3ds
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.1
ui70faq
20 Jan 22
XORTX Announces Appointment of Chief Technology Officer
7:00am
6-K
EX-99.2
yrw49q6tcqdmf afb5
10 Jan 22
XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference
7:01am
6-K
EX-99.2
5nh nm0rxmu6x
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am
- Prev
- 1
- Next